期刊文献+

乳腺癌脑转移患者血清CEA、CA153与预后的关系 被引量:2

原文传递
导出
摘要 目的探讨乳腺癌脑转移时血清肿瘤标志物血清癌胚抗原(CEA)、人肿瘤相关抗原153(CA153)与患者预后的关系。方法回顾性分析乳腺癌患者发生脑转移时CEA、CA153与生存期长短之间的关系。结果乳腺癌脑转移时高血清CEA水平与预后负相关(P〈0.05),CA153与预后无相关性。多因素分析显示CEA〉5ng/ml是乳腺癌脑转移的预后不良因素(P=0.014)。结论乳腺癌脑转移患者高血清CEA水平提示预后不佳,生存期短,是乳腺癌脑转移的独立预后因素。
出处 《中国实用医刊》 2013年第3期95-95,100,共2页 Chinese Journal of Practical Medicine
  • 相关文献

参考文献9

  • 1Lin NU,Bellon JR,Winer EP. CNS metastases in breast cancer[J].Journal of Clinical Oncology,2004,(17):3608-3617.doi:10.1200/JCO.2004.01.175.
  • 2Yau T,Swanton C,Chua S. Incidence,pattem and timing of brain among patients with advanced breast cancer treated witll trastuzumab[J].Acta Oncologica,2006,(02):196-201.
  • 3Liu MT,Hsieh CY,Wang AY. Prognostic factors affecting the outcome of brain metastases from breast cancer[J].Supportive Care in Cancer,2006,(09):936-942.
  • 4AJ Evans,James JJ,Comford EJ. Brain Metastases from Breast Cancer:identification of a high-risk group[J].Clinical Oncology,2004,(05):345-349.doi:10.1016/j.clon.2004.03.012.
  • 5白冰,袁中玉,刘冬耕,滕小玉,王树森.不同亚型乳腺癌脑转移患者的临床特征和生存分析[J].癌症,2010,29(4):453-461. 被引量:10
  • 6Gaspar LS,cott CR,otman MA. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials[J].I nt J Radiat Oncol BiolPhys,1997,(04):745-751.
  • 7Arrietao,Saavedra-Perezl D,Kuri R. Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer:a prospective analysis[J].BMC Cancer,2009,(02):119.
  • 8Noura S,Ohue M,Shingai T. Brain metastasis colorectal cancer:prognostic factors and survival[J].Journal of Surgical Oncology,2012,(02):144-148.
  • 9Sandri MT,Salvatici M,Botteri E. Prognostic role of CA15-3 in 7942 patients with operable breast cancer[J].Breast Cancer Research and Treatment,2012,(01):317-326.

二级参考文献25

  • 1Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001 ) in the Metropolitan Detroit Cancer Surveillance System [ J]. J Clin Oncol, 2004,22 (14) :2865-2872.
  • 2Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer [J]. J Clin Oncol, 2004,22(17) :3608-3617.
  • 3Patanaphan V, Salazar OM, Risco R. Breast cancer : Metastatic patterns and their prognosis [ J]. South Med J, 1985,81(9) :1109-1112.
  • 4Tsukada Y, Fouad A, Pickren JW, et al. Central nervous system metastasis from breast carcinoma. Autopsy study [J]. Cancer, 1983,52(12) :2349-2354.
  • 5Lin NU, Claus E, Sohl J, et al. Sites of Distant recurrence and clinical outcomes in patients with metastatic triple-negative beast cancer [ J ]. Cancer, 2008,113(10) :2638-2645.
  • 6Dawood S, Broglio K, Esteva F J, et al. Survival among women with triple receptor-negative breast cancer and brain metastases [J]. Ann Oncol, 2009,20(4) :621- 627.
  • 7Nam BH, Kim SY, Han HS, et al. Breast cancer subtypes and survival in patients with brain metastases [J]. Breast Cancer Res, 2008,10(1) :R20.
  • 8Gabos Z, Sinha R, Hanson J, et al. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer [ J]. J Clin Oncol, 2006, 24 (36) : 5658-5663.
  • 9Pestalozzi BC, Zahrieh D, Price KN, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG) [ J]. Ann Oncol, 2006, 17(6) :935-944.
  • 10Hicks DG, Short SM, Prescott NL, et al. Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and over express HER2 or EGFR [ J]. Am J Surg Pathol, 2006,30 (9) : 1097-1104.

共引文献9

同被引文献23

  • 1Lakhani SR, Ellis I0, Schnitt SJ, et al. WHO classification of tumours of the breast[M]. Lyon,France:IARC Press ,2012 :100-109.
  • 2Wang GP, Zhang H, Zhang ZF, et al. Clinical and pathological char- acteristics of intraductal proliferative lesions and coexist with invasive ductal carcinomas [ J ]. Chinses-German J Clin Oncol, 20 1 3,12 ( 12 ) :574-580.
  • 3Chang JM, Cho N, Moon WK, et al. Does ultrasound-guided directional vacuum-assisted removal help eliminate abnormal nipple discharge in patients with benign intraductal single mass [ J ]. Korean J Radiol, 2009,10(6) :575-580.
  • 4Dolan RT, Butler JS, Kell MR, et al. Nipple discharge and the efficacyof duct cytology in evaluating breast cancer risk[ J ]. Surgeon, 2010, 8 (5) : 252-258.
  • 5Sabel MS,klelvie MA, Breshn T, et al. ls duct excision stil necessary for all cases of suspicious nipple discharge[ J ]. Breast J, 2012, 18 (2) :157- 162.
  • 6Parthasarathy V, Rathnarn U. Nipple discharge : an early warning sign of breast cancer[ J]. Im J Prey Med,2012,3 (11 ) :810-814.
  • 7Cken L,Zhou WB ,Zhao Y ,et al. Bloody nipple discharge is a predic- tor of breast cancer risk:a recta-analysis [ J ]. Breast Cancer Res Treat, 2012,132(1 ) :9-14.
  • 8周凯,闵大六.消化道恶性肿瘤中多种肿瘤标志物蛋白芯片联合检测的研究进展[J].解剖与临床,2009(4):300-302. 被引量:2
  • 9宋红伟,王雅杰.三种血清肿瘤标志物联合检测对恶性肿瘤的诊断价值[J].实用癌症杂志,2009,24(5):483-485. 被引量:10
  • 10李继广,任更朴,蔡庆岭.CA153、CA125与细针吸取细胞学联检在乳腺癌诊断中的应用价值[J].中国实用医刊,2011,38(2):1-2. 被引量:5

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部